rs150306354

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000081.4(LYST):​c.7870C>T​(p.Arg2624Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00343 in 1,613,734 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2624Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 17 hom. )

Consequence

LYST
NM_000081.4 missense

Scores

2
13
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 2.29

Publications

12 publications found
Variant links:
Genes affected
LYST (HGNC:1968): (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]
LYST Gene-Disease associations (from GenCC):
  • Chediak-Higashi syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • attenuated Chédiak-Higashi syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.051336676).
BP6
Variant 1-235746438-G-A is Benign according to our data. Variant chr1-235746438-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 454488.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0027 (411/152166) while in subpopulation NFE AF = 0.00435 (296/68004). AF 95% confidence interval is 0.00394. There are 1 homozygotes in GnomAd4. There are 226 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYSTNM_000081.4 linkc.7870C>T p.Arg2624Trp missense_variant Exon 29 of 53 ENST00000389793.7 NP_000072.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYSTENST00000389793.7 linkc.7870C>T p.Arg2624Trp missense_variant Exon 29 of 53 5 NM_000081.4 ENSP00000374443.2

Frequencies

GnomAD3 genomes
AF:
0.00270
AC:
411
AN:
152048
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000580
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.00680
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00435
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00269
AC:
675
AN:
251312
AF XY:
0.00270
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00541
Gnomad NFE exome
AF:
0.00397
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00351
AC:
5125
AN:
1461568
Hom.:
17
Cov.:
31
AF XY:
0.00342
AC XY:
2487
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33462
American (AMR)
AF:
0.000537
AC:
24
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00159
AC:
137
AN:
86248
European-Finnish (FIN)
AF:
0.00631
AC:
337
AN:
53414
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5766
European-Non Finnish (NFE)
AF:
0.00395
AC:
4396
AN:
1111784
Other (OTH)
AF:
0.00318
AC:
192
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
278
555
833
1110
1388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00270
AC:
411
AN:
152166
Hom.:
1
Cov.:
32
AF XY:
0.00304
AC XY:
226
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.000578
AC:
24
AN:
41504
American (AMR)
AF:
0.000654
AC:
10
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4818
European-Finnish (FIN)
AF:
0.00680
AC:
72
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00435
AC:
296
AN:
68004
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00347
Hom.:
3
Bravo
AF:
0.00209
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00372
AC:
32
ExAC
AF:
0.00277
AC:
336
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00354
EpiControl
AF:
0.00243

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Chédiak-Higashi syndrome Uncertain:1Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LYST NM_000081.3 exon 29 p.Arg2624Trp (c.7870C>T): This variant has been reported in the literature in 1 individual with Hemophagocytic Lymphohistiocytosis (HLH) (Mukda 2017 PMID:28353193). However, this variant is present in 0.5% (142/25120) of Finnish alleles, including 1 homozygote, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-235909738-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:454488). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

not specified Benign:2
Jan 03, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 27, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LYST-related disorder Benign:1
Jul 03, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LYST: BS1 -

Autoinflammatory syndrome Benign:1
Apr 04, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.60
D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.97
D
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.051
T
MetaSVM
Uncertain
-0.13
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
2.3
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.48
Sift
Uncertain
0.0020
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.85
MVP
0.51
ClinPred
0.015
T
GERP RS
3.4
Varity_R
0.34
gMVP
0.54
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150306354; hg19: chr1-235909738; COSMIC: COSV67715039; COSMIC: COSV67715039; API